$INO Expect INO share price to head straight down next week: Feb. 7, 2020 6:59 PM ET Inovio Pharmaceuticals (NASDAQ:INO) is down 4.1% postmarket after filing an amendment to its at-the-market equity offering sales agreement with Stifel Nicolaus. That increases the amount the company can offer to $200M from $100M. Since Sept. 30, the company has sold about $68.3M of common stock pursuant to their agreement.
  • 6